GSK PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,766 GBX | +2.11% |
|
-0.45% | +21.81% |
| 10:07pm | Delaware judge lets more than 70,000 Zantac lawsuits go forward | RE |
| 09:35am | GSK Regarding Ruling By Delaware State Court On Zantac Litigation Will Immediately Seek Appeal | RE |
Chart calendar GSK plc
87435c1be6ba88d104879367a9d3e0._dLdi5NbzSFyOUXpNVAlCIlMnCOVnoMWuXEpfUbvc9s.0KOr4-c2_BkFcjaYQTZAfLw4pGfS1OF64B5LEhmhK5KlqoL88Wz4Zxx1Kg~dcebbe62660f5d8ef5000a74a248f89e
Upcoming events on GSK plc
Past events on GSK plc
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #8627 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #LBA3512 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #8017 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #7530 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #TPS5627 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #e19523 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #TPS6125 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #e19532 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #e19524 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #e19507 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #e19503 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #7559 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #e23110 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - MV. Mateos |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #7503 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #7543 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #5606 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #5607 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #TPS3174 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - #e23106 |
Past dividends on GSK plc
| 2024-05-15 | Interim Payment 0.15 GBP |
| 2024-02-21 | Final Payment 0.16 GBP |
| 2023-11-15 | Interim Payment 0.14 GBP |
| 2023-08-16 | Interim Payment 0.14 GBP |
| 2023-05-17 | Interim Payment 0.14 GBP |
| 2023-02-22 | Final Payment 0.1375 GBP |
| 2022-11-16 | Interim Payment 0.1375 GBP |
| 2022-08-17 | Interim Payment 0.1625 GBP |
| 2022-07-17 | 0 GBP |
| 2022-05-18 | Interim Payment 0.14 GBP |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 33 754 33 382 1.11% | 34 099 34 076 0.07% | 34 114 34 029 0.25% | 29 324 29 105 0.75% | 30 328 29 850 1.6% | 31 636 |
|
EBITDA Million GBP | Released Forecast Spread | 11 968 11 155 7.28% | 9 530 10 575 -9.88% | 11 330 10 048 12.76% | 10 449 9 257 12.88% | 11 635 10 203 14.04% | 10 568 |
|
EBIT Million GBP | Released Forecast Spread | 8 972 9 182 -2.29% | 8 906 8 955 -0.55% | 8 806 8 717 1.02% | 8 151 7 952 2.5% | 8 786 8 780 0.07% | 9 179 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 6 221 5 926 4.97% | 6 968 6 763 3.02% | 5 442 5 794 -6.07% | 5 628 5 548 1.45% | 6 064 7 498 -19.12% | 7 386 |
|
Net income Million GBP | Released Forecast Spread | 4 645 4 026 15.38% | 5 749 4 894 17.46% | 4 385 3 990 9.91% | 14 956 6 238 139.74% | 4 928 5 481 -10.09% | 5 555 |
|
EPS GBP | Released Forecast Spread | 1,16 1,06 9.69% | 1,43 1,21 17.91% | 1,08 1,02 6.28% | 3,66 1,66 120.52% | 1,22 1,38 -11.61% | 1,37 |
| Announcement Date | 05/02/20 | 03/02/21 | 09/02/22 | 01/02/23 | 31/01/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 9 780 9 145 6.94% | 6 929 6 906 0.33% | 7 829 7 214 8.52% | 7 376 7 101 3.88% | 6 951 6 580 5.64% | 7 178 6 795 5.63% | 8 147 7 727 5.43% | 8 052 7 621 5.65% | 7 363 7 060 4.3% | 7 533 | 8 534 | 8 219 | 7 590 | 7 865 |
|
EBITDA Million GBP | Released Forecast Spread | 3 317 2 850 16.4% | 2 639 2 138 23.45% | 3 561 2 704 31.68% | 1 602 1 855 -13.63% | 2 732 2 418 12.97% | 2 622 2 506 4.64% | 3 351 3 072 9.09% | 2 930 2 094 39.93% | 2 992 2 406 24.36% | 2 594 | 3 095 | 1 835 | ||
|
EBIT Million GBP | Released Forecast Spread | 2 613 2 291 14.06% | 2 008 1 740 15.4% | 2 605 2 264 15.08% | 1 595 1 509 5.7% | 2 092 1 930 8.42% | 2 170 1 999 8.56% | 2 772 2 570 7.88% | 1 752 1 836 -4.58% | 2 443 2 099 16.38% | 2 216 | 2 793 | 1 757 | 2 408 | 2 487 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 2 598 2 268 14.55% | 896 1 243 -27.89% | 1 012 1 860 -45.59% | 1 626 946 71.97% | 1 907 1 529 24.72% | 1 987 1 500 32.51% | 1 791 2 225 -19.51% | 379 1 361 -72.15% | 1 355 1 696 -20.11% | 1 823 | 2 493 | 1 317 | ||
|
Net income Million GBP | Released Forecast Spread | 1 802 1 674 7.66% | 975 802 21.54% | 10 315 1 356 660.76% | 1 495 1 151 29.9% | 1 490 1 179 26.41% | 1 624 1 213 33.86% | 1 464 1 739 -15.79% | 350 834 -58.04% | 1 046 1 297 -19.32% | 1 425 | 1 877 | 1 214 | ||
|
EPS GBP | Released Forecast Spread | 0,45 0,41 8.83% | 0,21 0,21 -3.22% | 2,52 0,34 640.73% | 0,37 0,19 95.19% | 0,37 0,29 27.52% | 0,40 0,30 35.52% | 0,36 0,43 -15.26% | 0,09 0,20 -58.02% | 0,25 0,31 -19.17% | 0,35 | 0,46 | 0,23 | ||
| Announcement Date | 27/04/22 | 27/07/22 | 02/11/22 | 01/02/23 | 26/04/23 | 26/07/23 | 01/11/23 | 31/01/24 | 01/05/24 | - | - | - | - | - |
More events
Past sector events for GSK plc
| 2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 05:26 am | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 04:44 am | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 04:10 am | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-28 | PFIZER LIMITED: Q4 2024 Earnings Release |
| 2024-05-27 | DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release |
| 2024-05-27 08:10 am | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GSK Stock
- Calendar GSK plc
